Literature DB >> 6729888

Behavioral performance of rats following transient forebrain ischemia.

B T Volpe, W A Pulsinelli, J Tribuna, H P Davis.   

Abstract

Rats subjected to transient forebrain ischemic injury by the method of four vessel occlusion (4-VO) develop irreversible injury to select populations of vulnerable neurons which include pyramidal cells in the CA-1 region of the hippocampus. This brain area is thought to be crucial for learning and memory. Rats subjected to 30 minutes of 4-VO, and then cerebral reperfusion were tested on a radial 8-arm maze task after they had recovered. The data shows that both 4-VO and control animals improve their performance over trials, but that 4-VO rats are impaired on "working" and "reference" tasks. The data suggest that 4-VO rats' impaired "working" performance is permanent, compared to their transient "reference" impairment. Alterations in sensorimotor activity could not account for these performance deficits since control and 4-VO rats demonstrated equivalent choice time per maze arm. Performance deficits in rats following forebrain ischemic injury may be similar to some of the cognitive deficits found in humans survivors of cerebral hypoxia-ischemia.

Entities:  

Mesh:

Year:  1984        PMID: 6729888     DOI: 10.1161/01.str.15.3.558

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  16 in total

1.  Functional assessments in the rodent stroke model.

Authors:  Krystal L Schaar; Miranda M Brenneman; Sean I Savitz
Journal:  Exp Transl Stroke Med       Date:  2010-07-19

2.  Two-stage resuscitation of the cat brain after prolonged cardiac arrest.

Authors:  K Seo; S Ishimaru; K A Hossmann
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

3.  Thrombolysis using plasminogen activator and heparin reduces cerebral no-reflow after resuscitation from cardiac arrest: an experimental study in the cat.

Authors:  M Fischer; B W Böttiger; S Popov-Cenic; K A Hossmann
Journal:  Intensive Care Med       Date:  1996-11       Impact factor: 17.440

4.  Prohibitin viral gene transfer protects hippocampal CA1 neurons from ischemia and ameliorates postischemic hippocampal dysfunction.

Authors:  Hitomi Kurinami; Munehisa Shimamura; Tao Ma; Liping Qian; Kenzo Koizumi; Laibaik Park; Eric Klann; Giovanni Manfredi; Costantino Iadecola; Ping Zhou
Journal:  Stroke       Date:  2014-03-11       Impact factor: 7.914

5.  No-reflow after cardiac arrest.

Authors:  M Fischer; K A Hossmann
Journal:  Intensive Care Med       Date:  1995-02       Impact factor: 17.440

6.  In utero hypoxic ischemia decreases the cholinergic agonist-stimulated poly-phosphoinositide turnover in the developing rat brain.

Authors:  K Hersey; Z Y Hu; J P Zhang; P G Rhodes; G Y Sun
Journal:  Neurochem Res       Date:  1995-12       Impact factor: 3.996

7.  Dentate granule cells form hilar basal dendrites in a rat model of hypoxia-ischemia.

Authors:  Sofia Díaz-Cintra; Baogang Xue; Igor Spigelman; K Van; Alan M Wong; Andre Obenaus; Charles E Ribak
Journal:  Brain Res       Date:  2009-06-17       Impact factor: 3.252

8.  So you think you can jump? A novel long jump assessment to detect deficits in stroked mice.

Authors:  Nitish Mittal; Jie Pan; Julie Palmateer; Lianna Martin; Arushi Pandya; Sungita Kumar; Adaora Ofomata; Patricia D Hurn; Timothy Schallert
Journal:  J Neurosci Methods       Date:  2015-09-11       Impact factor: 2.390

9.  Suppression of hippocampal TRPM7 protein prevents delayed neuronal death in brain ischemia.

Authors:  Hong-Shuo Sun; Michael F Jackson; Loren J Martin; Karen Jansen; Lucy Teves; Hong Cui; Shigeki Kiyonaka; Yasuo Mori; Michael Jones; Joan P Forder; Todd E Golde; Beverley A Orser; John F Macdonald; Michael Tymianski
Journal:  Nat Neurosci       Date:  2009-09-06       Impact factor: 24.884

10.  Intraspecies behavior of animals based on a model of experimental brain ischemia.

Authors:  V P Poshivalov; L N Dorokhova; V A Sorokoumov
Journal:  Neurosci Behav Physiol       Date:  1988 Sep-Oct
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.